Literature DB >> 12675265

Report of eight new cases of hypnic headache and mini-review of the literature.

Natascia Ghiotto1, Grazia Sances, Giorgio Di Lorenzo, Marco Trucco, Marianna Loi, Giorgio Sandrini, Giuseppe Nappi.   

Abstract

Hypnic headache is a rare condition first described by Raskin in 1988. This headache is not included in the first edition of the International Headache Society classification (IHC 1st Edition). We describe eight new Italian hypnic headache cases and consider our findings in the light of literature data. Our cases do not completely fulfil the diagnostic criteria for the syndrome proposed in 1997 by Goadsby and Lipton: four of our patients reported an attack duration longer than 60 minutes (ranging from 3 to 10 hours) and five reported unilateral pain. These data are in line with an analysis of all 61 cases published in the literature to date, which reveals a pain duration of over 60 minutes in 45.9% of the cases and unilateral attacks in 36%. Hypnic headache will be included in the fourth chapter (Other Primary Headaches) of the revised edition of the above-mentioned classification (IHC 2nd Edition).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12675265

Source DB:  PubMed          Journal:  Funct Neurol        ISSN: 0393-5264


  4 in total

1.  Hypnic headache: clinical course and treatment.

Authors:  Hans-Christoph Diener; Mark Obermann; Dagny Holle
Journal:  Curr Treat Options Neurol       Date:  2012-02       Impact factor: 3.598

Review 2.  Secondary "hypnic headache".

Authors:  Raquel Gil-Gouveia; Peter J Goadsby
Journal:  J Neurol       Date:  2007-04-03       Impact factor: 4.849

Review 3.  Mechanism of action of indomethacin in indomethacin-responsive headaches.

Authors:  Oliver Summ; Stefan Evers
Journal:  Curr Pain Headache Rep       Date:  2013-04

Review 4.  Focus on therapy of hypnic headache.

Authors:  Carlo Lisotto; Paolo Rossi; Cristina Tassorelli; Enrico Ferrante; Giuseppe Nappi
Journal:  J Headache Pain       Date:  2010-06-29       Impact factor: 7.277

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.